These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2078911)

  • 1. Ferrous sulfate reduces methyldopa absorption: methyldopa: iron complex formation as a likely mechanism.
    Campbell NR; Campbell RR; Hasinoff BB
    Clin Invest Med; 1990 Dec; 13(6):329-32. PubMed ID: 2078911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of an effect of ferrous sulfate on phenytoin absorption in the rat.
    Campbell NR; Hasinoff BB; Robertson S; Singh M
    Clin Invest Med; 1993 Aug; 16(4):280-4. PubMed ID: 8306537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of trivalent iron in oral iron preparations. Therapeutic efficacy and iron absorption from simple ferric compounds and high- or low-molecular weight ferric hydroxide-carbohydrate complexes.
    Heinrich HC
    Arzneimittelforschung; 1975 Mar; 25(3):420-6. PubMed ID: 1174047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of fasting and/or oxidizing and reducing agents on absorption of neptunium from the gastrointestinal tract of mice and adult or neonatal rats.
    Sullivan MF; Ruemmler PS; Ryan JL
    Radiat Res; 1984 Dec; 100(3):519-26. PubMed ID: 6505141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of ferrous sulfate and pH on L-dopa absorption.
    Campbell RR; Hasinoff B; Chernenko G; Barrowman J; Campbell NR
    Can J Physiol Pharmacol; 1990 May; 68(5):603-7. PubMed ID: 2340448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of methyldopa absorption, metabolism, and blood pressure control caused by ferrous sulfate and ferrous gluconate.
    Campbell N; Paddock V; Sundaram R
    Clin Pharmacol Ther; 1988 Apr; 43(4):381-6. PubMed ID: 3356082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased treatment failure rates following duodenal release ferrous glycine sulfate in iron deficiency anemia associated with autoimmune gastritis and Helicobacter pylori gastritis.
    Hershko C; Ianculovich M; Souroujon M
    Acta Haematol; 2007; 118(1):19-26. PubMed ID: 17426393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron absorption by human subjects from different iron fortification compounds added to Thai fish sauce.
    Walczyk T; Tuntipopipat S; Zeder C; Sirichakwal P; Wasantwisut E; Hurrell RF
    Eur J Clin Nutr; 2005 May; 59(5):668-74. PubMed ID: 15756294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of orally administered iron with levodopa and methyldopa therapy.
    Greene RJ; Hall AD; Hider RC
    J Pharm Pharmacol; 1990 Jul; 42(7):502-4. PubMed ID: 1980293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability, absorption mechanism, and toxicity of microencapsulated iron (I) sulfate: studies in mice.
    Boccio JR; Zubillaga MB; Caro RA; Lysionek A; Gotelli CA; Gotelli MJ; Weill R
    Biol Trace Elem Res; 1998; 62(1-2):65-73. PubMed ID: 9630425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal absorption of alpha-methyldopa: in vitro mechanistic studies in rat small intestinal segments.
    Osiecka I; Cortese M; Porter PA; Borchardt RT; Fix JA; Gardner CR
    J Pharmacol Exp Ther; 1987 Aug; 242(2):443-9. PubMed ID: 3612544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferrous sulfate reduces cimetidine absorption.
    Campbell NR; Hasinoff BB; Meddings JB; Anderson WD; Robertson S; Granberg K
    Dig Dis Sci; 1993 May; 38(5):950-4. PubMed ID: 8482196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of iron salts and ferric hydroxide-carbohydrate complexes.
    Geisser P; Müller A
    Arzneimittelforschung; 1987 Jan; 37(1A):100-4. PubMed ID: 3566862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative evaluation of spermicidal activities of iron salts.
    Safaya S; Sikka SC; Sharma BR; Laumas KH
    Indian J Exp Biol; 1979 May; 17(5):465-8. PubMed ID: 521063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of anti-anaemic effects of iron protein succinylate (ITF 282) and ferrous sulfate in the rat.
    Caramazza I; Andriuoli G; Scagnol I; Del Soldato P
    Drugs Exp Clin Res; 1990; 16(7):333-42. PubMed ID: 2092959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of an effect of oral iron administration on mycophenolic acid pharmacokinetics in stable renal transplant recipients.
    Gelone DK; Park JM; Lake KD
    Pharmacotherapy; 2007 Sep; 27(9):1272-8. PubMed ID: 17723081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral iron therapy in human subjects, comparative absorption between ferrous salts and iron polymaltose.
    Jacobs P; Johnson G; Wood L
    J Med; 1984; 15(5-6):367-77. PubMed ID: 6599114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equivalent bioavailability of iron from ferrous salts and a ferric polymaltose complex. Clinical and experimental studies.
    Jacobs P
    Arzneimittelforschung; 1987 Jan; 37(1A):113-6. PubMed ID: 3566865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the absorption of divalent and trivalent iron in living rats.
    Schäfer S; Forth W
    Arzneimittelforschung; 1984; 34(11):1570-4. PubMed ID: 6543132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural cytochemistry of iron absorption.
    Parmley RT; Barton JC; Conrad ME; Austin RL
    Am J Pathol; 1978 Dec; 93(3):707-27. PubMed ID: 717544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.